Price
106.14
+3.27%52W Range
Market Cap
₹977.55 Cr
Traded: ₹1.32 Cr (0.14%) 0.0x
Free Float: ₹248.59 Cr (0.53% of FF traded)
Volume · 60D trend
1.26 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | +11.0% | +12.0% | +6.0% | -- | -- | Stable |
| Return | +7.0% | -2.0% | -14.0% | -1.0% | -- | Stable |
| Profit | -20.0% | -46.0% | -69.0% | -- | -321.0% | Decelerating |
| Sales | +4.0% | +8.0% | -1.0% | -- | -13.0% | Decelerating |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 87 | 77 | 90 | 78 | 98 | 72 | 94 | 117 | 123 | 98 | 83 | 105 | 97 | 80 | 89 | 91 |
| Expenses | 139 | 73 | 80 | 81 | 108 | 79 | 88 | 100 | 94 | 89 | 74 | 92 | 75 | 70 | 74 | 70 |
| Operating Profit | -52 | 4 | 10 | -3 | -10 | -8 | 6 | 17 | 29 | 9 | 8 | 12 | 22 | 10 | 15 | 21 |
| OPM % | -60.0% | 4.9% | 11.0% | -4.0% | -10.0% | -11.0% | 6.0% | 15.0% | 24.0% | 10.0% | 10.0% | 12.0% | 22.0% | 13.1% | 17.0% | 23.4% |
| Other Income | 97 | 11 | 6 | 5 | 1 | 2 | 1 | 6 | 7 | 5 | 6 | 7 | 6 | 5 | 7 | 6 |
| Interest | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 39 | 9 | 10 | -3 | -14 | -11 | 2 | 18 | 31 | 9 | 8 | 14 | 23 | 10 | 18 | 23 |
| Tax % | 36.0% | 2.0% | 3.0% | 5.0% | 1.0% | -13.0% | 69.0% | 20.0% | 21.0% | 24.0% | 10.0% | 19.0% | 19.0% | 18.4% | 24.0% | 21.4% |
| Net Profit | 25 | 9 | 10 | -4 | -14 | -10 | 1 | 14 | 25 | 7 | 7 | 11 | 18 | 8 | 13 | 18 |
| Exceptional Items | 93 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
| EPS (Rs) | 2.7 | 1.0 | 1.1 | -0.4 | -1.5 | -1.1 | 0.1 | 1.6 | 2.7 | 0.7 | 0.8 | 1.2 | 2.0 | 0.9 | 1.4 | 1.9 |
| Sales Growth (YoY) | -11.2% | 6.9% | -4.3% | -33.3% | -20.3% | -26.5% | 13.3% | 11.4% | 26.8% | 22.4% | -6.7% | 15.4% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 13.0% | -14.4% | 15.4% | -20.4% | 36.1% | -23.4% | -19.7% | -4.9% | 25.5% | 18.1% | -20.9% | 8.3% | 21.1% | -10.0% | -2.2% | -- |
| OP Growth (YoY) | -420.0% | 150.0% | 66.7% | -117.6% | -134.5% | -188.9% | -25.0% | 41.7% | 31.8% | -14.1% | -46.7% | -43.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | -1400.0% | -60.0% | 433.3% | 70.0% | -25.0% | -233.3% | -64.7% | -41.4% | 222.2% | 12.5% | -33.3% | -45.5% | 109.9% | -30.1% | -29.7% | -- |
| Profit Growth (YoY) | -282.0% | 192.0% | 2002.0% | -125.0% | -158.0% | -245.0% | -93.0% | 26.0% | 36.0% | -21.0% | -45.0% | -36.0% | 5.0% | -15.0% | 7.0% | -8.0% |
| EPS Growth (YoY) | 273.4% | 192.4% | 1733.3% | -125.2% | -157.5% | -245.8% | -92.5% | 26.0% | 35.4% | -20.9% | -44.8% | -36.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 175.3% | -11.8% | 382.1% | 74.7% | -46.7% | -1850.0% | -96.1% | -42.2% | 272.2% | -10.0% | -35.0% | -37.9% | 117.6% | -37.2% | -24.9% | -- |
| OP Margin | -59.8% | 5.2% | 11.1% | -3.9% | -10.2% | -11.1% | 6.4% | 14.5% | 23.6% | 9.2% | 9.6% | 11.4% | 22.7% | 13.1% | 16.9% | 23.4% |
| Net Margin | 28.7% | 11.7% | 11.1% | -5.1% | -14.3% | -13.9% | 1.1% | 12.0% | 20.3% | 7.1% | 8.4% | 10.5% | 18.6% | 10.5% | 14.6% | 19.5% |
| Material Cost % | 67.0% | 31.0% | 32.0% | 31.0% | 54.0% | 29.0% | 30.0% | 36.0% | 34.0% | 40.0% | 32.0% | 40.0% | 30.0% | 34.7% | 37.6% | 30.3% |
| Employee Cost % | 26.0% | 28.0% | 25.0% | 32.0% | 25.0% | 36.0% | 27.0% | 21.0% | 18.0% | 23.0% | 24.0% | 19.0% | 21.0% | 22.1% | 18.7% | 17.0% |
| P/S | 2.94 | 2.92 | 3.10 | 2.32 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 24.40 | 776.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.46 | 2.51 | 2.76 | 2.08 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
Newspaper Publication of Un-audited Financial Results for the quarter ended 30th June, 2026
Investors Presentation for the quarter ended 30.06.2026
Investors Presentation for the quarter ended 30.06.2026
Please refer to the attachment.
Please refer to the attachment.
Please refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
Kindly refer to the attachment.
Please refer to the outcome of the Board Meeting held on 13th August 2026.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Vividhmargi Investments Pvt Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi ....
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 21, 2026 for Vividhmargi Trust
The Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 16, 2026 for Vividhmargi Investments Pvt Ltd
Please refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Vividhmargi Trust
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Intimation of Closure of Trading Window.
Please refer to the attachment.
The Exchange has sought clarification from Themis Medicare Ltd on June 23, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Annual Secretarial Compliance Report for the financial year ended 31st March, 2026
Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026
Please refer to the attachment.
Please refer to the Investor Presentation of the Company for the quarter ended 31.03.2026
1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2026 together with the Report issued by the Statutory Auditors, M/s. Krishaan ....
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Please refer to the attachment.
Newspaper Publication of Notice to Shareholders for Special Window for re-lodgement of transfer request and dematerialization of physical shares.
RTA Compliance Certificate under Reg 74(5) of SEBI (DP)Regulations, 2018 for the quarter ended 31st March, 2026.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vividhmargi Investments Pvt Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vividhmargi Investments Pvt Ltd
Voting Results & Scrutinizer''s Report of Postal Ballot.
Scrutinizer''s Report of Postal Ballot.
Please refer to our Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015.
Intimation of Closure of Trading Window for the declaration of audited standalone & consolidated financial results for the quarter and year ending on 31st March, 2026.
Newspaper Publication of Corrigendum to the Notice of Postal Ballot dated 25.02.2026
Please refer to the attachment.
Please refer to the attachment.
Newspaper Advertisement pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015.
Please refer to the attachment
Please refer to the attachment
Newspaper Publication of un-audited financial results for the quarter and nine months ended 31st December, 2025
Please refer to the attachment.
Please refer to the attachment
Please refer to the atachment.
Please refer the attachment.
Please refer to the attachment.
Themis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Update on board meeting
Annual Reports
14Credit Ratings
6Concalls
15Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Held by ETFs
1 ETFs hold themismed · sorted by weight
Held by Mutual Funds
1 schemes hold themismed · sorted by weight